DEPENDENCE OF CLINIC INDICATORS FROM LEVEL OF SYSTEMIC INFLAMMATION IN PATIENTS WITH PSORIATIC ILLNESS

Authors:

Abstract:

On the basis of study of 40 patients with uncomplicated plaque psoriasis of moderate severity with concomitant metabolic syndrome shown association clinical and laboratory parameters of the level of systemic inflammation, which is important for therapies aimed at preventing the development of clinical exacerbation of psoriasis and the extension of the period of remission.

Keywords:

psoriasis metabolic syndrome indicators of systemic inflammation

References:

1. Європейське керівництво з лікування хворих на цукровий діабет із серцевосудинною патологією (2007). Ліки України, березень, 2007. – №109. – С. 12.
2. Сариан Е.И. Дисфункция эндотелия у больных псориазом и статины / Е.И Сариан. // Международный медицинский журнал-2012.-№3.-С.89-93.
3. Свінціцький А.С. Метаболічні порушення у хворих на псоріаз і псоріатичний артрит/ А.С. Свінціцький // Здоров’я України.-2010.-№1.-С.69-71.
4. Grundy S.M. Diagnosis and management of the metabolic syndrome: an American Heart Association/ S.M.Grundy, J.I.Cleeman, S.R. Daniels [ et al. ] //National Heart, Lung, and Blood Institute scientific statement // Circulation. – 2005. – Vol. 112. – P. 2735–2752.
5. Guerrero-Romero F. Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions / F. Guerrero-Romero, M. Rodriguez-Moran // Diabetes Care. – 2005. – Vol. 28. –P. 2588–2589.
6. Grundy S.M. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement / S.M. Grundy, J.I. Cleeman, S.R. Daniels [ et al.] // Circulation. – 2005. – Vol. 112. – P. 2735–2752.
7. Guerrero-Romero F. Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National holesterol Education Program Adult Treatment Panel III and the World Health Organization definitions / F. Guerrero-Romero, M. Rodriguez-Moran // Diabetes Care. – 2005. – Vol. 28.–P. 2588–2589.
8. Laakso M. Insulin resistance and coronary heart disease / M. Laakso // Curr. Opin. Lipidol. –1996. – Vol. 7. – P. 217–226.
9. Nograles K. E. IL-22-producing ‘‘T22’’ T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. / K. E. Nograles, L. C. Zaba // J. Allergy Clin. Immunol. – 2009. – № 123. – Р. 1244–125241
10. Pereira M.G. Dyadic adjustment, family coping, body image, quality of life and psychological morbidity in patients with psoriasis and their partners./ M.G. Pereira, L Brito., T. Smith // Int. J. Behav. Med. – 2011 – Jun 25.;
11. Pereira M.G. Dyadic adjustment, family coping, body image, quality of life and psychological morbidity in patients with psoriasis and their partners. / M.G. Pereira, L. Brito, T.Smith / M.G. Pereira // Int. J. Behav. Med. – 2011 – Jun 25.
12. Sahin Е. Adiponectin levels, insulin resistance and their reletionship with serum levels of inflammatory cytokines in patients with Behcets disease / Е. Sahin // JEADV. – 2012. –№ 12. – Р. 1498–1502.;
13. Sterry W. Obesity in psoriasis: the metabolic, clinical and therapeutic implications / W. Sterry // BAD. – 2007. – № 157(4). – Р. 649–655.
14. Zheng Y. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. / Y. Zheng, D.M. Danilenko // Nature – 2007. – № 445 – Р. 648–651.

Publication:

«World of Medicine and Biology» Vol. 10 No. 45 (2014) , с. 40-43
УДК 616.517-002-008